close
Choose Your Site
Global
Social Media
Views: 0 Author: Site Editor Publish Time: 2026-07-03 Origin: Site
As the global weight management market continues to expand, consumer demand for natural, safe, and multi-pathway weight control ingredients has never been stronger. Naruhibis® Roselle HCA Powder is a patented branded ingredient from World-Way Biotech Inc., specifically positioned in the "appetite suppression and fat reduction" segment. Derived from the calyces of Roselle (Hibiscus sabdariffa L.) through advanced extraction technology, this product boasts a core specification of ≥40% Hydroxycitric Acid (HCA), complemented by naturally co-occurring hibiscus acid, anthocyanins, and polyphenols, forming a unique dual-pathway system of "appetite control + fat blocking."
Unlike conventional roselle concentrates (typically dark red), Naruhibis® Roselle HCA Powder presents as a fine yellow powder with excellent water solubility, offering exceptional formulation flexibility. The product holds ECOCERT, EU Organic, and USDA Organic certifications, along with HALAL, KOSHER, ISO 9001, and FSSC 22000 v6.0 certifications, positioning it as a premier weight management ingredient in the global market.
Roselle (Hibiscus sabdariffa L.), also known as Jamaican sorrel or red sorrel, belongs to the Malvaceae family. It is an annual herbaceous plant widely distributed across tropical and subtropical regions. The calyx—fleshy, deep crimson, and nutrient-rich—is the most valued part, traditionally used both as food and medicine. In China, roselle is recognized as a common food ingredient; in the United States, it holds FDA GRAS (Generally Recognized as Safe) status; and in the European Union, diuretic function claims are permitted for its extracts.
World-Way Biotech has meticulously selected raw materials from 15 premium growing regions worldwide, specifically harvesting the most prized calyx portions. Analytical testing reveals that the natural HCA content of World-Way’s selected raw materials is nearly double that of commercially available generic sources, establishing a superior foundation for subsequent high-concentration standardization.
● Hydroxycitric Acid (HCA): ≥40% – The core bioactive compound that competitively inhibits ATP-citrate lyase (ACLY), blocking the metabolic conversion of carbohydrates into fat at the molecular source.
● Hibiscus Acid: A roselle-specific organic acid that synergistically enhances HCA’s efficacy.
● Anthocyanins: Potent natural antioxidants providing additional metabolic health benefits.
● Polyphenols: Including gallic acid, chlorogenic acid, caffeoylquinic acid, and protocatechuic acid, offering anti-inflammatory, antioxidant, and lipid-lowering effects.
Dual-Pathway Mechanism:
Pathway 1 – Intracellular Fat Synthesis Blockade: High-concentration HCA competitively inhibits the activity of ATP-citrate lyase (ACLY), the rate-limiting enzyme that channels excess carbohydrates into fatty acid synthesis. By blocking ACLY, HCA effectively shuts down the "excess sugar → fat" conversion pathway, reducing new adipogenesis (de novo lipogenesis) at the cellular level.
Pathway 2 – Central Nervous System Appetite Regulation: HCA elevates serotonin (5-hydroxytryptamine) levels in the brain. Serotonin is a key neurotransmitter intimately linked with mood and satiety. Clinical assessments show that increased serotonin directly signals satiety to the brain, significantly improving subjective fullness scores while reducing hunger and food craving ratings—particularly beneficial for those struggling with emotional eating.
1. Appetite Suppression and Craving Control: Elevates serotonin to enhance satiety and reduce food cravings. Clinical data demonstrates significantly improved fullness scores and reduced hunger ratings.
2. Fat Synthesis Blockade: Inhibits the conversion of excess carbohydrates into fat at the cellular level, reducing fat accumulation at its source rather than merely blocking carbohydrate absorption.
3. Lipid Profile Improvement: Naturally co-occurring polyphenols and anthocyanins exhibit significant lipid-lowering activity, improving metabolic profiles.
4. Potent Antioxidant and Anti-inflammatory Activity: Rich polyphenol and anthocyanin content provides excellent antioxidant capacity (ORAC value), protecting cells from oxidative damage.
5. Efficacy Timeline: Appetite regulation effects typically manifest within 1–2 weeks; measurable body composition changes emerge at 8–12 weeks (with balanced diet and regular exercise).
Naruhibis® is positioned as a premium branded ingredient for the "appetite suppression, fat reduction, and metabolic regulation" segment, primarily targeting cross-border and international health markets. World-Way Biotech employs a "Branded Ingredient" marketing model, allowing partner brands to feature the "Powered by Naruhibis®" mark on finished product packaging.
Recommended dosage: 500–1000 mg/day (as HCA), divided into two servings with meals. Suitable dosage forms include powdered drink mixes, oral liquids, hard capsules, tablets, and pressed candies. Compatible with green tea extract (EGCG), chromium picolinate, and soluble dietary fiber for synergistic formulations.
Competitive advantages over Garcinia cambogia HCA: Naruhibis® additionally contains hibiscus acid and a natural anthocyanin/polyphenol complex, achieving triple synergy—fat synthesis inhibition + serotonergic appetite control + antioxidant/anti-inflammatory protection. Compared to white kidney bean extract (solely an intestinal α-amylase inhibitor), Naruhibis® operates at both cellular metabolic and central nervous system levels for deeper, more comprehensive intervention.
1. Overweight and obese individuals seeking weight control
2. Body-shaping enthusiasts and fitness aficionados looking to reduce body fat
3. Individuals struggling with appetite control and emotional eating
4. Advanced fat-loss seekers who need cellular-level fat synthesis inhibition beyond simple carb blocking
5. Consumers seeking alternatives to single-mechanism carbohydrate blockers
● LD₅₀: >5,000 mg/kg body weight (rat model) – classified as practically non-toxic
● NOAEL: No adverse effects observed in 90-day long-term feeding studies at doses exceeding 10× the recommended human dose
● Human clinical safety: No serious adverse events reported with 1,000 mg HCA/day for 12 weeks; occasional mild gastrointestinal discomfort typically resolves with continued use
● 100% plant-derived (roselle calyx), free from animal-derived processing aids or excipients, and free from common allergens (gluten, lactose, soy)
● Precautions: Not recommended for infants, pregnant or lactating women; diabetic patients advised to monitor blood glucose during initial use
Naruhibis® Roselle HCA Powder redefines weight management with its innovative "cellular synthesis blockade + neural appetite control" dual-pathway mechanism. Compared to conventional HCA sources (Garcinia cambogia) and single-mechanism carbohydrate blockers (white kidney bean), Naruhibis® offers a more comprehensive, deeper-acting weight control solution. Backed by World-Way Biotech’s rigorous quality systems (triple organic certification, HALAL, KOSHER, FSSC 22000), premium raw material sourcing from 15 global growing regions, and complete preclinical and clinical safety data, this ingredient is positioned as a star performer in the international premium weight management market.
